|
2025-03-06 |
2025-03-06 |
S
Sale
|
DENNER ALEXANDER J
Large shareholder
|
1,196,746
-17.5%
17.52
USD 20,964,237
|
1,196,746
-17.5%
|
17.52
|
USD 20,964,237
|
|
|
2025-03-06 |
2025-03-05 |
S
Sale
|
DENNER ALEXANDER J
Large shareholder
|
270,374
-3.8%
17.63
USD 4,766,126
|
270,374
-3.8%
|
17.63
|
USD 4,766,126
|
|
|
2025-03-06 |
2025-03-04 |
S
Sale
|
DENNER ALEXANDER J
Large shareholder
|
151,175
-2.1%
17.63
USD 2,665,079
|
151,175
-2.1%
|
17.63
|
USD 2,665,079
|
|
|
2023-11-17 |
2023-11-15 |
S
Sale
|
Zhen Marianne
Chief Accounting Officer
Officer
|
5,405
-11.9%
13.97
USD 75,508
|
5,405
-11.9%
|
13.97
|
USD 75,508
|
|
|
2023-11-17 |
2023-11-15 |
S
Sale
|
Zhen Marianne
Chief Accounting Officer
Officer
|
5,589
-10.9%
14.01
USD 78,302
|
5,589
-10.9%
|
14.01
|
USD 78,302
|
|
|
2023-06-20 |
2023-06-15 |
B
Purchase
|
DENNER ALEXANDER J
Large shareholder
|
62,000
+0.9%
13.13
USD 814,196
|
62,000
+0.9%
|
13.13
|
USD 814,196
|
|
|
2023-06-07 |
2023-06-06 |
B
Purchase
|
DENNER ALEXANDER J
Large shareholder
|
8,000
+0.1%
13.05
USD 104,384
|
8,000
+0.1%
|
13.05
|
USD 104,384
|
|
|
2023-06-07 |
2023-06-05 |
B
Purchase
|
DENNER ALEXANDER J
Large shareholder
|
7,000
+0.1%
13.04
USD 91,297
|
7,000
+0.1%
|
13.04
|
USD 91,297
|
|
|
2023-05-30 |
2023-05-30 |
B
Purchase
|
DENNER ALEXANDER J
Large shareholder
|
120,000
+1.7%
13.01
USD 1,560,648
|
120,000
+1.7%
|
13.01
|
USD 1,560,648
|
|
|
2023-05-30 |
2023-05-26 |
B
Purchase
|
DENNER ALEXANDER J
Large shareholder
|
30,000
+0.4%
13.12
USD 393,729
|
30,000
+0.4%
|
13.12
|
USD 393,729
|
|
|
2023-05-30 |
2023-05-25 |
B
Purchase
|
DENNER ALEXANDER J
Large shareholder
|
50,000
+0.7%
13.09
USD 654,330
|
50,000
+0.7%
|
13.09
|
USD 654,330
|
|
|
2023-05-19 |
2023-05-18 |
B
Purchase
|
DENNER ALEXANDER J
Large shareholder
|
10,000
+0.1%
13.05
USD 130,538
|
10,000
+0.1%
|
13.05
|
USD 130,538
|
|
|
2023-05-19 |
2023-05-17 |
B
Purchase
|
DENNER ALEXANDER J
Large shareholder
|
50,000
+0.7%
13.07
USD 653,690
|
50,000
+0.7%
|
13.07
|
USD 653,690
|
|
|
2023-05-15 |
2023-05-11 |
B
Purchase
|
DENNER ALEXANDER J
Large shareholder
|
290,000
+4.4%
12.34
USD 3,577,411
|
290,000
+4.4%
|
12.34
|
USD 3,577,411
|
|
|
2023-03-14 |
2023-03-10 |
PP
Planned purchase
|
Raifeld Pavel
Chief Executive Officer
Officer
|
3,000
+44.1%
10.87
USD 32,603
|
3,000
+44.1%
|
10.87
|
USD 32,603
|
|
|
2021-05-25 |
2021-05-24 |
B
Purchase
|
Bickerstaff George
Non-Executive Director
|
10,000
+8.7%
13.46
USD 134,619
|
10,000
+8.7%
|
13.46
|
USD 134,619
|
|
|
2021-05-25 |
2021-05-21 |
B
Purchase
|
Bickerstaff George
Non-Executive Director
|
10,000
+9.6%
12.97
USD 129,670
|
10,000
+9.6%
|
12.97
|
USD 129,670
|
|
|
2021-05-24 |
2021-05-20 |
S
Sale
|
GLAXOSMITHKLINE PLC
Large shareholder
|
32,005,260
-100.0%
12.25
USD 392,064,435
|
32,005,260
-100.0%
|
12.25
|
USD 392,064,435
|
|
|
2020-02-24 |
2020-02-24 |
S
Sale
|
Zhen Marianne
Chief Accounting Officer
Officer
|
2,954
-11.9%
14.78
USD 43,660
|
2,954
-11.9%
|
14.78
|
USD 43,660
|
|
|
2019-02-28 |
2019-02-27 |
B
Purchase
|
Bickerstaff George
Non-Executive Director
|
15,000
+38.7%
15.90
USD 238,500
|
15,000
+38.7%
|
15.90
|
USD 238,500
|
|
|
2019-02-28 |
2019-02-26 |
S
Sale
|
Zhen Marianne
Chief Accounting Officer
Officer
|
5,617
-23.1%
16.00
USD 89,872
|
5,617
-23.1%
|
16.00
|
USD 89,872
|
|
|
2019-02-22 |
2019-02-21 |
B
Purchase
|
Bickerstaff George
Non-Executive Director
|
10,000
+34.8%
14.90
USD 148,958
|
10,000
+34.8%
|
14.90
|
USD 148,958
|
|
|
2019-02-20 |
2019-02-15 |
B
Purchase
|
HULME GEOFFREY
Interim PEO
Officer
|
7,000
+inf%
14.80
USD 103,600
|
7,000
+inf%
|
14.80
|
USD 103,600
|
|
|
2018-08-22 |
2018-08-21 |
PS
Planned sale
|
ABERCROMBIE GEORGE B
Sr. VP & Chief Comm. Officer
Officer
|
8,000
-2.7%
14.11
USD 112,840
|
8,000
-2.7%
|
14.11
|
USD 112,840
|
|
|
2018-08-22 |
2018-08-21 |
S
Sale
|
Witek Theodore J. Jr.
Sr. VP & Chief Scientific Off.
Officer
|
8,504
-3.3%
14.12
USD 120,080
|
8,504
-3.3%
|
14.12
|
USD 120,080
|
|
|
2018-05-22 |
2018-05-21 |
PS
Planned sale
|
ABERCROMBIE GEORGE B
Sr. VP & Chief Comm. Officer
Officer
|
8,000
-2.6%
14.40
USD 115,202
|
8,000
-2.6%
|
14.40
|
USD 115,202
|
|
|
2018-05-22 |
2018-05-21 |
PS
Planned sale
|
dEsparbes Eric
SVP and CFO
Officer
|
5,808
-1.5%
14.40
USD 83,623
|
5,808
-1.5%
|
14.40
|
USD 83,623
|
|
|
2018-02-22 |
2018-02-21 |
PS
Planned sale
|
Witek Theodore J. Jr.
Sr. VP & Chief Scientific Off.
Officer
|
9,890
-5.0%
16.60
USD 164,148
|
9,890
-5.0%
|
16.60
|
USD 164,148
|
|
|
2018-02-22 |
2018-02-21 |
PS
Planned sale
|
ABERCROMBIE GEORGE B
Sr. VP & Chief Comm. Officer
Officer
|
8,000
-3.3%
16.51
USD 132,100
|
8,000
-3.3%
|
16.51
|
USD 132,100
|
|
|
2018-02-22 |
2018-02-21 |
PS
Planned sale
|
dEsparbes Eric
Interim PEO, SVP and CFO
Officer
|
5,378
-1.8%
16.52
USD 88,825
|
5,378
-1.8%
|
16.52
|
USD 88,825
|
|
|
2017-12-05 |
2017-12-04 |
S
Sale
|
Aguiar Michael W
President & Chief Exec Officer
Executive Director
|
12,022
-1.2%
13.13
USD 157,791
|
12,022
-1.2%
|
13.13
|
USD 157,791
|
|
|
2017-11-22 |
2017-11-21 |
PS
Planned sale
|
Witek Theodore J. Jr.
Sr. VP & Chief Scientific Off.
|
13,000
-5.7%
13.29
USD 172,795
|
13,000
-5.7%
|
13.29
|
USD 172,795
|
|
|
2017-11-22 |
2017-11-21 |
PS
Planned sale
|
ABERCROMBIE GEORGE B
Sr. VP & Chief Comm. Officer
|
5,215
-2.0%
13.26
USD 69,145
|
5,215
-2.0%
|
13.26
|
USD 69,145
|
|
|
2017-11-22 |
2017-11-21 |
PS
Planned sale
|
dEsparbes Eric
SVP and CFO
|
13,460
-4.0%
13.31
USD 179,171
|
13,460
-4.0%
|
13.31
|
USD 179,171
|
|
|
2017-11-22 |
2017-11-20 |
PS
Planned sale
|
dEsparbes Eric
SVP and CFO
|
1,825
-0.5%
13.04
USD 23,798
|
1,825
-0.5%
|
13.04
|
USD 23,798
|
|
|
2017-08-22 |
2017-08-21 |
PS
Planned sale
|
dEsparbes Eric
SVP and CFO
|
1,825
-0.5%
12.20
USD 22,265
|
1,825
-0.5%
|
12.20
|
USD 22,265
|
|
|
2017-05-23 |
2017-05-22 |
PS
Planned sale
|
Witek Theodore J. Jr.
Sr. VP & Chief Scientific Off.
Officer
|
7,815
-3.1%
12.01
USD 93,858
|
7,815
-3.1%
|
12.01
|
USD 93,858
|
|
|
2017-05-23 |
2017-05-22 |
PS
Planned sale
|
dEsparbes Eric
SVP and CFO
Officer
|
1,825
-0.5%
11.85
USD 21,626
|
1,825
-0.5%
|
11.85
|
USD 21,626
|
|
|
2017-02-22 |
2017-02-21 |
PS
Planned sale
|
dEsparbes Eric
SVP and CFO
Officer
|
1,825
-0.5%
12.07
USD 22,028
|
1,825
-0.5%
|
12.07
|
USD 22,028
|
|
|
2016-11-22 |
2016-11-22 |
PS
Planned sale
|
WITEK THEODORE L JR
Sr. VP & Chief Scientific Off.
Officer
|
3,700
-2.4%
10.84
USD 40,123
|
3,700
-2.4%
|
10.84
|
USD 40,123
|
|
|
2016-11-22 |
2016-11-21 |
PS
Planned sale
|
dEsparbes Eric
SVP and CFO
Officer
|
1,800
-0.8%
10.89
USD 19,602
|
1,800
-0.8%
|
10.89
|
USD 19,602
|
|
|
2016-08-23 |
2016-08-22 |
PS
Planned sale
|
dEsparbes Eric
SVP and CFO
Officer
|
3,700
-1.5%
11.77
USD 43,549
|
3,700
-1.5%
|
11.77
|
USD 43,549
|
|
|
2016-05-20 |
2016-05-18 |
PS
Planned sale
|
Tyree James L
Non-Executive Director
|
813
-1.6%
10.47
USD 8,512
|
813
-1.6%
|
10.47
|
USD 8,512
|
|
|
2015-05-29 |
2015-05-27 |
S
Sale
|
WALTRIP WILLIAM H
Non-Executive Director
|
16,313
-11.7%
16.32
USD 266,228
|
16,313
-11.7%
|
16.32
|
USD 266,228
|
|
|
2014-08-15 |
2014-08-13 |
S
Sale
|
LEE JUNNING
Sr. VP, Technical Operations
Officer
|
53,424
-16.8%
22.50
USD 1,202,040
|
53,424
-16.8%
|
22.50
|
USD 1,202,040
|
|
|
2014-08-13 |
2014-08-12 |
S
Sale
|
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Officer
|
1,048
-0.2%
22.30
USD 23,370
|
1,048
-0.2%
|
22.30
|
USD 23,370
|
|
|
2014-08-13 |
2014-08-11 |
S
Sale
|
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Officer
|
27,108
-5.7%
22.12
USD 599,629
|
27,108
-5.7%
|
22.12
|
USD 599,629
|
|
|
2014-03-05 |
2014-03-03 |
PS
Planned sale
|
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Officer
|
1,800
-0.5%
37.23
USD 67,014
|
1,800
-0.5%
|
37.23
|
USD 67,014
|
|
|
2014-03-05 |
2014-03-03 |
PS
Planned sale
|
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Officer
|
64,006
-16.3%
36.72
USD 2,350,300
|
64,006
-16.3%
|
36.72
|
USD 2,350,300
|
|
|
2014-02-19 |
2014-02-14 |
PS
Planned sale
|
Mammen Mathai
SVP, Research & Early Clin Dev
Officer
|
4,600
-2.4%
40.04
USD 184,184
|
4,600
-2.4%
|
40.04
|
USD 184,184
|
|
|
2013-06-11 |
2013-06-07 |
S
Sale
|
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Officer
|
31,038
-9.3%
35.04
USD 1,087,572
|
31,038
-9.3%
|
35.04
|
USD 1,087,572
|
|
|
2013-05-15 |
2013-05-13 |
PS
Planned sale
|
Brinkley David L
Head of Business Dev.
Officer
|
16,129
-22.7%
40.33
USD 650,483
|
16,129
-22.7%
|
40.33
|
USD 650,483
|
|
|
2013-05-07 |
2013-05-03 |
PS
Planned sale
|
Brinkley David L
Head of Business Dev.
Officer
|
16,129
-22.7%
34.77
USD 560,805
|
16,129
-22.7%
|
34.77
|
USD 560,805
|
|
|
2013-05-02 |
2013-04-30 |
PS
Planned sale
|
Mammen Mathai
SVP, Research & Early Clin Dev
Officer
|
200
-0.1%
34.34
USD 6,868
|
200
-0.1%
|
34.34
|
USD 6,868
|
|
|
2013-05-02 |
2013-04-30 |
PS
Planned sale
|
Brinkley David L
Head of Business Dev.
Officer
|
100
-0.2%
34.35
USD 3,435
|
100
-0.2%
|
34.35
|
USD 3,435
|
|
|
2013-05-02 |
2013-04-30 |
PS
Planned sale
|
Brinkley David L
Head of Business Dev.
Officer
|
17,004
-23.6%
33.76
USD 574,055
|
17,004
-23.6%
|
33.76
|
USD 574,055
|
|
|
2013-05-02 |
2013-04-30 |
PS
Planned sale
|
Aguiar Michael W
Sr VP, Chief Financial Officer
Officer
|
10,100
-6.6%
34.34
USD 346,834
|
10,100
-6.6%
|
34.34
|
USD 346,834
|
|
|
2013-05-02 |
2013-04-30 |
PS
Planned sale
|
Aguiar Michael W
Sr VP, Chief Financial Officer
Officer
|
160,779
-51.3%
33.77
USD 5,429,507
|
160,779
-51.3%
|
33.77
|
USD 5,429,507
|
|
|
2013-05-02 |
2013-04-30 |
PS
Planned sale
|
Winningham Rick E
Chief Executive Officer
Executive Director
|
1,577
-0.2%
34.32
USD 54,123
|
1,577
-0.2%
|
34.32
|
USD 54,123
|
|
|
2013-05-02 |
2013-04-30 |
PS
Planned sale
|
Winningham Rick E
Chief Executive Officer
Executive Director
|
253,955
-26.0%
33.64
USD 8,543,046
|
253,955
-26.0%
|
33.64
|
USD 8,543,046
|
|
|
2013-02-22 |
2013-02-20 |
PS
Planned sale
|
Mammen Mathai
SVP, Research & Early Clin Dev
Officer
|
7,000
-3.2%
22.14
USD 154,980
|
7,000
-3.2%
|
22.14
|
USD 154,980
|
|
|
2012-11-06 |
2012-11-02 |
PS
Planned sale
|
Mammen Mathai
SVP, Research & Early Clin Dev
Officer
|
200
-0.1%
22.53
USD 4,506
|
200
-0.1%
|
22.53
|
USD 4,506
|
|
|
2012-08-28 |
2012-08-27 |
PS
Planned sale
|
Aguiar Michael W
Sr VP, Chief Financial Officer
Officer
|
2,861
-2.1%
27.86
USD 79,707
|
2,861
-2.1%
|
27.86
|
USD 79,707
|
|
|
2012-08-28 |
2012-08-27 |
PS
Planned sale
|
Aguiar Michael W
Sr VP, Chief Financial Officer
Officer
|
17,700
-11.6%
27.24
USD 482,148
|
17,700
-11.6%
|
27.24
|
USD 482,148
|
|
|
2012-08-28 |
2012-08-24 |
PS
Planned sale
|
Aguiar Michael W
Sr VP, Chief Financial Officer
Officer
|
4,121
-2.6%
28.01
USD 115,429
|
4,121
-2.6%
|
28.01
|
USD 115,429
|
|
|
2012-08-15 |
2012-08-13 |
PS
Planned sale
|
Mammen Mathai
SVP, Research & Early Clin Dev
Officer
|
3,108
-1.4%
26.15
USD 81,274
|
3,108
-1.4%
|
26.15
|
USD 81,274
|
|
|
2012-08-09 |
2012-08-07 |
PS
Planned sale
|
Aguiar Michael W
Sr VP, Chief Financial Officer
Officer
|
60,000
-27.5%
27.04
USD 1,622,400
|
60,000
-27.5%
|
27.04
|
USD 1,622,400
|
|
|
2012-08-07 |
2012-08-03 |
PS
Planned sale
|
Brinkley David L
Head of Business Dev.
Officer
|
123,917
-65.0%
27.92
USD 3,459,763
|
123,917
-65.0%
|
27.92
|
USD 3,459,763
|
|
|
2012-08-07 |
2012-08-03 |
PS
Planned sale
|
Winningham Rick E
Chief Executive Officer
Executive Director
|
36,200
-5.8%
28.15
USD 1,019,030
|
36,200
-5.8%
|
28.15
|
USD 1,019,030
|
|
|
2012-08-07 |
2012-08-03 |
PS
Planned sale
|
Winningham Rick E
Chief Executive Officer
Executive Director
|
39,549
-5.9%
27.77
USD 1,098,276
|
39,549
-5.9%
|
27.77
|
USD 1,098,276
|
|
|
2012-05-31 |
2012-05-29 |
S
Sale
|
Aguiar Michael W
Sr VP, Chief Financial Officer
Officer
|
20,000
-11.2%
22.29
USD 445,800
|
20,000
-11.2%
|
22.29
|
USD 445,800
|
|
|
2012-05-16 |
2012-05-16 |
B
Purchase
|
GLAXOSMITHKLINE PLC
Large shareholder
|
10,000,000
+63.2%
21.29
USD 212,887,000
|
10,000,000
+63.2%
|
21.29
|
USD 212,887,000
|
|
|
2012-05-02 |
2012-05-01 |
S
Sale
|
DRAZAN JEFFREY M
Non-Executive Director
|
8,586
-20.4%
21.71
USD 186,402
|
8,586
-20.4%
|
21.71
|
USD 186,402
|
|
|
2011-12-13 |
2011-12-09 |
S
Sale
|
Aguiar Michael W
Sr VP, Chief Financial Officer
Officer
|
10,000
-5.1%
21.86
USD 218,600
|
10,000
-5.1%
|
21.86
|
USD 218,600
|
|
|
2011-11-30 |
2011-11-28 |
PS
Planned sale
|
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Officer
|
20,000
-5.4%
21.00
USD 420,000
|
20,000
-5.4%
|
21.00
|
USD 420,000
|
|
